Drug intelligence / Profile preview

sasanquasaponin III

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

**Sasanquasaponin III** is a triterpenoid saponin, originally isolated from the flower buds of *Camellia sasanqua* and also found in the seeds of *Camellia oleifera* and the roots and stems of *Schima superba* and *Schima crenata*.[3][7][2] The chemical structure consists of a triterpenoid aglycone moiety linked to a sugar chain, typically a di- or trisaccharide.[2][3] Sasanquasaponin III exhibits a range of pharmacological activities, including anti-cancer (notably inhibiting epithelial to mesenchymal transition and promoting apoptosis in prostate cancer and melanoma cells[1][7]), anti-fungal (notably against *Candida albicans*[3]), and anti-inflammatory effects (by attenuating NF-κB and MAPK signaling pathways[5]). Its anti-tumor effects are thought to involve inhibition of the PI3K/Akt/mTOR, Smad2/3, and Akt/mTOR/p70S6K pathways, modulation of apoptosis-related markers (Bax, Bcl-2, caspase-3), and induction of autophagy.[1][7][9][5] It is under investigation mainly as a naturally derived bioactive compound from traditional Chinese medicine sources.

Other names
SQS III
02

Targets

ErgosterolAKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)

Beyond the preview

Go deeper on sasanquasaponin III.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sasanquasaponin III.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call